US2016220671A1PendingUtilityA1
Method Of Administration To A Patient Suffering From Disturbances In Vascular Tone
Est. expiryDec 26, 2021(expired)· nominal 20-yr term from priority
A61K 2039/505C07K 16/26C07K 16/2869C07K 16/2878C07K 16/40A61K 41/0004A61P 37/00C07K 16/241A61P 9/02A61K 39/395A61P 9/12A61P 9/00
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The method of treatment for diseases accompanied by disturbances of the vascular tone utilizes the use of ultra low doses of antibodies to a protein or a peptide involved in the vascular tone regulation or mediating the effects of other regulators; these antibodies are used in activated form produced by multiple subsequent dilution and external impact.
Claims
exact text as granted — not AI-modified1 - 10 . (canceled)
11 . A method of administering to a patient suffering from a disease or condition associated with disturbances of the vascular tone, a homeopathically potentized form of at least one antibody to angiotensin receptor.
12 . The method of claim 12 wherein said antibody is selected from monoclonal, polyclonal or natural antibodies.
13 . The method of claim 12 wherein said antibody to angiotensin receptor is to the angiotensin II receptor.
14 . The method of claim 12 wherein said antibody to angiotensin receptor is to the angiotensin I receptor.
15 . The method of claim 12 wherein said antibody to angiotensin receptor is to the C-terminal fragment of the angiotensin II receptor.
16 . The method of claim 12 , wherein said homeopathically potentized form comprises one or more homeopathic dilutions.
17 . The method of claim 17 , wherein said one or more homeopathic dilutions comprises one or more centesimal homeopathic dilutions.
18 . The method of claim 17 , wherein said one or more homeopathic dilutions comprises C12, C30, and C200 homeopathic dilutions.
19 . The method of claim 17 , wherein said one or more homeopathic dilutions comprises C6, C12, and C200 homeopathic dilutions.
20 . The method of claim 12 wherein the disease or condition is hypotension.Join the waitlist — get patent alerts
Track US2016220671A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.